Resources from the same session
Introduction
Presenter: Christoph Benedikt Westphalen
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
Pre-clinical development of targeted agents: Change of mindset from tumour type to mechanism of action
Presenter: Elena Garralda
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
DRUP (Drug Repurposing) trial and beyond: Learning from DRUP 1.0
Presenter: Karlijn Verkerk
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
Fast-tracking preclinical research to pan-cancer trials: Success stories and less so
Presenter: Vivek Subbiah
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
Biomarker-driven immunotherapies: How relevant is being tumour type-specific?
Presenter: Aurélien Marabelle
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast
Q&A
Presenter: Christoph Benedikt Westphalen
Session: New trial designs, new paths to drug registration
Resources:
Webcast
Towards harmonised design and interpretation of histology agnostic, biomarker driven trials: The ESMO Precision Medicine Working Group initiative
Presenter: Christoph Benedikt Westphalen
Session: New trial designs, new paths to drug registration
Resources:
Slides
Webcast